A naukri.com initiative
Bioengineer
5d
282
Image Credit: Bioengineer
Multi-Modal Radiomics Predicts Breast Cancer Response
- A pioneering multi-modal radiomics model was developed to predict pathological complete response (pCR) to neoadjuvant treatment in breast cancer patients by integrating ultrasound, mammography, computed tomography, and magnetic resonance imaging.
- This innovative approach aims to enhance the accuracy of treatment outcome predictions as neoadjuvant therapies gain importance in breast cancer management.
- The study conducted a retrospective analysis of 89 breast cancer patients, leveraging radiomic data from multiple imaging modalities to evaluate tumor heterogeneity and treatment-induced changes.
- Utilizing the least absolute shrinkage and selection operator (LASSO), robust radiomic features were selected to create a multi-modal radiomics framework, complemented by clinical risk factors.
- Individual imaging modalities demonstrated moderate predictive power, with CT radiomics showing the highest single-modality AUC, followed by MRI, mammography, and ultrasound.
- The integration of all four radiomic signatures into a multi-modal model resulted in a significantly enhanced AUC and impressive predictive accuracy, further improved by incorporating clinical risk factors.
- The study's nomogram visualization tool allows clinicians to estimate individualized treatment response probabilities, facilitating personalized therapeutic decisions based on the model's predictions.
- This paradigm-shifting research challenges the reliance on single-modality imaging in radiomics, emphasizing the value of a multi-modal approach for a comprehensive understanding of tumor response to treatment.
- The development of such models could revolutionize therapeutic decision-making by minimizing overtreatment, identifying alternative strategies, and improving patient outcomes through tailored neoadjuvant regimens.
- By combining advanced imaging technology with clinical insights, multi-modal radiomics models are poised to play a pivotal role in advancing personalized oncology and improving patient prognosis.
Read Full Article
16 Likes
For uninterrupted reading, download the app